T1	outcome 1053 1064	Amenorrhoea
T2	intervention 0 26	Complete hormonal blockade
T3	control 34 63	epirubicin-based chemotherapy
T5	location 199 205	French
T6	eligibility 354 453	premenopausal patients with hormone receptor positive breast cancer and one to three positive nodes
T7	total-participants 469 472	333
T8	outcome 766 800	7-year disease-free survival (DFS)
T9	iv-bin-percent 805 808	76%
T10	cv-bin-percent 829 832	72%
T11	outcome 858 886	7-year overall survival (OS)
T12	iv-bin-percent 891 894	91%
T13	cv-bin-percent 899 902	88%
T14	cv-bin-percent 1077 1080	64%
T4	intervention-participants 601 604	164
T15	control-participants 756 759	169
T16	iv-bin-percent 1133 1136	58%
T17	cv-bin-percent 1174 1177	31%
